Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"

NCT03555578 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03555578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03555578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Drug-Use Survey of Leuprorelin Acetate Injection Kit 11.25 mg "All-Case Investigation: Spinal and Bulbar Muscular Atrophy (SBMA)"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
November 2, 2017
Completion date
April 30, 2026
Enrollment
1,905 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal and bulbar muscular atrophy